Travaux scientifiques

Doç. Dr. Lale Aydın Kaynar

30 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Comparative prognostic performance of ELN 2022 and ELN 2024 risk classifications in a Turkish cohort of acute myeloid leukemia patients receiving hypomethylating agents and BCL-2 inhibitors

    Acta Medica, 2026

    DOI 10.32552/actamedica.2026.1271 Texte intégral en libre accèsSource : OpenAlex

  2. C-Reactive Protein-to-Albumin Ratio (CAR) as a Prognostic Biomarker in Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Therapy: A Single-Center Retrospective Cohort Study

    Hitit Medical Journal, 2026

    DOI 10.52827/hititmedj.2012111 Texte intégral en libre accèsSource : OpenAlex

  3. Thrombotic and hemorrhagic complications in NPM1-mutated AML: Association with APL-like immunophenotype and impact on early mortality

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03410-4 PMID 42878784 Source : OpenAlex

  4. Prognostic Impact of Serum Albumin Levels at Diagnosis in Patients with Chronic Lymphocytic Leukemia

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15031315 PMID 41682996 Texte intégral en libre accèsSource : Europe PMC

  5. Adherence to prophylaxis in adults with hemophilia: the role of communication, self-ınfusion, and ınfusion timing

    Journal of Current Hematology & Oncology Research, 2026

    DOI 10.51271/jchor-0080 Texte intégral en libre accèsSource : OpenAlex

  6. Overview of Acute Myeloid Leukemia with TP53 Mutation: Single Center, Real-Life Data

    Hitit Medical Journal, 2025

    DOI 10.52827/hititmedj.1628279 Texte intégral en libre accèsSource : OpenAlex

  7. Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignancies

    Annals of Hematology, 2024

    DOI 10.1007/s00277-024-05977-5 PMID 39235491 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  8. Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0194 PMID 37877113 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  9. Salvage Autologous Hematopoietic Stem Cell Transplantation Versus Chemoimmunotherapy in Relapsed Multiple Myeloma Patients After First Transplantation; Single Center Data

    Journal of Ankara University Faculty of Medicine, 2023

    DOI 10.4274/atfm.galenos.2023.83713 Texte intégral en libre accèsSource : OpenAlex

  10. Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort

    Leukemia Research, 2023

    DOI 10.1016/j.leukres.2023.107332 PMID 37307678 7 citations (OpenAlex) Source : OpenAlex

  11. The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients

    Cureus, 2023

    DOI 10.7759/cureus.46105 PMID 37779681 Texte intégral en libre accèsSource : OpenAlex

  12. COVID-19 Enfeksiyonunun Hematolojik Maligniteli Hastalar Üzerine Etkiler

    LLM Dergi, 2023

    DOI 10.5578/llm.20239902 Texte intégral en libre accèsSource : OpenAlex

  13. Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis

    Annals of hematology, 2022

    DOI 10.1007/s00277-022-04992-8 PMID 36195680 2 citations (Europe PMC) Source : Europe PMC

  14. Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia

    Annals of Hematology, 2022

    DOI 10.1007/s00277-022-04835-6 PMID 35460388 8 citations (OpenAlex) Source : OpenAlex

  15. Standart Prophylactic Granulocyte Colony Stimulating Factor Usage As A Part Of Autologous Stem Cell Transplantation Procedure

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.47113 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  16. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia

    Leukemia Research, 2022

    DOI 10.1016/j.leukres.2022.106870 PMID 35665626 9 citations (OpenAlex) Source : OpenAlex

  17. Gastrointestinal Sistemde Temel Semiyoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.684 Texte intégral en libre accèsSource : OpenAlex

  18. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

    Turkish Journal of Hematology, 2021

    DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  19. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.

    PubMed Central, 2021

    PMID 34322292 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  20. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

    Bursa Uludag University - AVESIS, 2021

    Source : OpenAlex

  21. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

    AYBU AVESIS, 2021

    Source : OpenAlex

  22. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study

    Hematology (Amsterdam, Netherlands), 2021

    DOI 10.1080/16078454.2021.1905355 PMID 33818297 9 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  23. Hematopoietic Cell Transplant-Composite Risk (HCT-CR): A Novel Predictor of Prognosis in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Transplantation Proceedings, 2021

    DOI 10.1016/j.transproceed.2021.06.017 PMID 34246474 Source : OpenAlex

  24. Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients

    Hematology, 2020

    DOI 10.1080/16078454.2020.1738097 PMID 32153257 11 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  25. Comparison of Post-Remission Strategies in Acute Myeloid Leukemia: Autologous Hematopoietic Stem Cell Transplantation versus Consolidation Chemotherapy

    Hematology Reports, 2020

    DOI 10.4081/hr.2020.8380 PMID 33324478 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  26. Hematopoietik Kök Hücre Nakli Olmuş Hastalarda JC Virüs Pozitifliğinin Gerçek-Zamanlı Polimeraz Zincir Reaksiyonu ile Araştırılması

    Flora the Journal of Infectious Diseases and Clinical Microbiology, 2020

    DOI 10.5578/flora.68466 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  27. The Eventual Role of Donor and Recipient Vitamin D Levels in Allogeneic Hematopoetic Stem Cell Transplant Setting

    Bursa Uludag University - AVESIS, 2020

    Source : OpenAlex

  28. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

    Blood, 2019

    DOI 10.1182/blood-2019-128743 Texte intégral en libre accèsSource : OpenAlex

  29. Efficacy of manual lymph drainage plus exercise on range of motion and flexibility in refractory chronic cutaneous graft-versus-host disease: A case report

    Current Research in Translational Medicine, 2019

    DOI 10.1016/j.retram.2019.11.001 PMID 31761680 3 citations (OpenAlex) Source : OpenAlex

  30. Hematolojik Maligniteli Hastalarda Nadir ve Mortal Bir Enfeksiyon Etkeni: Saprochaete capitata

    Mikrobiyoloji Bulteni, 2016

    DOI 10.5578/mb.28152 PMID 28124967 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex